About AstraZeneca K.K.
AstraZeneca has delivered many new drugs as a global pharmaceutical company, focusing on the therapeutic areas of cancer, respiratory diseases, and cardiovascular diseases. AstraZeneca's 2025 vision, with the mission of realizing patient-centricity through innovation, currently promotes open innovation in the areas of 4D+E (Digital, Diagnostics, Device, Drug and Experience), including drug discovery. In addition to actively promoting collaboration in these areas with startups, we have launched innovation hub in Japan "i2.JP" (https://www.i2jp.net/en/index.html)" in November 2020.
Corporate Profile of AstraZeneca K.K.
|Company Name||AstraZeneca K.K.|
|Business Overview||We provide cardiovascular, digestive, infectious diseases, neuroscience, tumor, and respiratory-related medical drugs. The company has operations in more than 100 countries, including emerging countries such as China, Brazil, India, and Russia. Global headquartered in London and Japan local headquarter is located in Osaka.|
|Type of Industry||Pharmaceutical|
Under the influence of COVID-19, we started a PoC on online medical care with MICIN.
Nov. 2020 Collaboration results
As an activity to promote open innovation in Japan, the innovation hub "i2. JP" and is launched and we are looking for partner companies.